LLMMedium
OpenAI’s GPT-3 Reported as Unviable in Medical Tasks by Healthcare Firm
- Occurred
- Oct 27, 2020
- Published
- Nov 1, 2022
- Source
- AI Incident Database
Summary
The French digital care company, Nabla, in researching GPT-3’s capabilities for medical documentation, diagnosis support, and treatment recommendation, found its inconsistency and lack of scientific and medical expertise unviable and risky in healthcare applications. This incident has been downgraded to an issue as it does not meet current ingestion criteria.
Developers
- OpenAI
- Nabla
Deployers
- none
Harmed parties
- Nabla customers
Classification
Category confidence: 90%
Severity confidence: 80%
Rationale: GPT-3 failure in medical tasks highlights LLM limitations in specialized domains without causing direct harm.
Classifier: Qwen/Qwen3.5-35B-A3B-FP8